ROBITUSSIN DRY COUGH

This brand name is authorized in Ireland, New Zealand, United Kingdom

Active ingredients

The drug ROBITUSSIN DRY COUGH contains one active pharmaceutical ingredient (API):

1 Demorphan UNII 9D2RTI9KYH - DEXTROMETHORPHAN HYDROBROMIDE

Dextromethorphan is a non-opioid antitussive drug. The major metabolite of dextromethorphan, dextrorphan, binds with high affinity to σ-receptors to produce its antitussive activity without exhibiting the classic opiate effects that occur from binding into μ- and δ-receptors. In larger than therapeutic doses, dextrorphan is also an antagonist of N-methyl-D-aspartate (NMDA) receptors. Read about Demorphan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ROBITUSSIN DRY COUGH MEDICINE Liquid for oral administration	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R05DA09	Dextromethorphan	R Respiratory system → R05 Cough and cold preparations → R05D Cough suppressants, excl. combinations with expectorants → R05DA Opium alkaloids and derivatives
Discover more medicines within R05DA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 214022, 46476
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 17375, 8860